Metabolic research
METABOLIC PATHWAYS
Metabolic Stack
A comparison-led stack that places three widely explored incretin-related materials side by side. These are alternatives for research comparison, not a suggested combined-use protocol.
Why these sit together
Semaglutide is GLP-1 focused, tirzepatide combines GLP-1 and GIP receptor activity, and retatrutide adds glucagon-receptor activity. They belong together as a progression of distinct metabolic research designs, not as materials intended to be combined.
Purchase every material in this stack as one grouped order. Component inventory remains connected behind the scenes.
Complete stack £197.99Currently unavailableINSIDE THE STACK
Each material,
clearly defined.
View research profile →
Metabolic research
Tirzepatide
Researchers study how it can help people feel fuller, eat less and manage glucose more effectively. It is an authorised medicine in specific forms and settings, but this research listing is not a treatment recommendation.
Metabolic research
Semaglutide
Researchers study how it slows stomach emptying, reduces hunger and helps the body control blood sugar. Authorised versions are used medically under professional supervision; this research product should not be treated as an authorised medicine.